100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
You Searched
₹810
Our Recommendation
Veenat 100mg Capsule 10s

254+ trust this
WHO GMP Certified


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Treatment of Cancer : In several types of cancers like blood cancers, gastrointestinal stromal tumors, skin cancer (dermatofibrosarcoma protuberans), and bone marrow condition (aggressive systemic mastocytosis), Imanex 100mg Capsule targets the specific proteins that contribute to the growth and spread of cancer cells. By stopping these proteins, the medicine slows down or even stops the growth of cancer. This helps shrink tumors, slow down their growth, and make the patients feel better.
Side effects of Imanex Capsule The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Imanex Edema (swelling)Nausea Vomiting Muscle cramp Musculoskeletal (bone, muscle or joint) pain Diarrhea Rash Fatigue Abdominal pain Bleeding Breathing problems Cough Weight gain Dry eye
How to use Imanex Capsule Follow your doctor's guidance regarding the dose and duration of this medication. Imanex 100mg Capsule is to be taken with food.
How Imanex Capsule works Imanex 100mg Capsule is an anti-cancer medication. A protein enzyme, bcr-abl tyrosine kinase, responsible for the growth of abnormal proliferation of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in bcr-abl positive cells (cancer cells). This is how it works to stop or slow the spread of cancer.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Imanex 100mg Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Imanex 100mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Imanex 100mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Lactating women should not breastfeed while using this drug and 15 days after stopping it.
Imanex 100mg Capsule may cause side effects which could affect your ability to drive.
Imanex 100mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Imanex 100mg Capsule may be needed. Doctor consultation is advised.
Imanex 100mg Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Imanex 100mg Capsule may be needed. Doctor consultation is advised.
If you forget a dose of Imanex 100mg Capsule , simply continue with your regular schedule and do not take a double dose.
G-040 Vikas Centre,106, S.V. Road, Santacruz West Mumbai City Mh 400054 India
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1732-34
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 953
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 692-94
Imatinib mesylate. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2001 (23 Jan. 2019)
Drugs and Lactation Database (LactMed) (18 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO) (26 Mar. 2019)
Natco Pharma Limited. Safety Data Sheet: Imatinib Mesylate. 2019 (05 Jul. 2023)
CiplaMed. Imatinib mesylate (05 Jul. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.